Apogee's Zumilokibart Shows Promise for Eczema in 2026
Apogee Therapeutics' zumilokibart showed skin clearance and itch relief for atopic dermatitis with less frequent injections in mid-stage trial results.
By Robert Kim
clinical trial
2 articles tagged "clinical trial"
Eli Lilly's Retatrutide Cuts Blood Sugar & Weight in Trial
Eli Lilly's triple-G drug retatrutide showed significant HbA1C and weight reductions in type 2 diabetes patients at 40 weeks in a 2026 late-stage trial.